PolTREG
- | Biotech or pharma, therapeutic R&D
Poltreg SA is a clinical stage SME that develops cellular therapy with T regulatory cells (Tregs) in the treatment of type 1 diabetes (prepare for phase III) and multiple sclerosis (prepare for phase II). There is also a new Treg prep in preclinical stage
Address
GdanskPomeranian Voivodeship
Poland
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}